Mini Poster - Stevens Johnson Syndrome

Embed Size (px)

Citation preview

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    1/21

    SANDY KARTIKA P C11108214

    NURUL AINI C11108785

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    2/21

    Patients IdentityName : Mrs. S

    Gender : Female

    Age : 56 years old

    Marital Status : Married

    Address : Jl. Vet. Utara LR 41/39

    Admission Date : 3 February 2012

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    3/21

    History TakingChief complaint : rupture of blisters on the back,

    chest, arms, abdomen, and lipatan paha

    Happen 1 week ago, starts with appear blisters

    on the left armpit and ruptured later. Shortlythereafter, the patient develops widespreadbullae that are easily ruptured.

    Post operation of mammae (7 days before)Medication History : Tamopen, Dexamethasone,

    Pirolesicam,

    Fever (+) 1 day before bulla presented

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    4/21

    Physical ExaminationAnemic (-), icterus (-), cyanoses (-)

    Erosion covering

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    5/21

    Current Status General status

    Composmentis

    Severe Sickness

    Adequate nutrition Moderate Hygiene

    Vital sign

    Blood pressure : 110/90mmHg

    Pulse rate : 80x/min

    Respiration rate : 24x/min

    Temperature : 36C

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    6/21

    Dermato-venerology StatusLocation 1 : Regio Mammae dextra,

    abdomen sinistra

    Effloresensi : Bulla

    Location 2 : Regio extremities superior et

    inferior,truncusposteriorEffloresensi : Bulla, vesicle, excoriation,

    erosion, epidermolysis

    Location 3 : Regio Mammae sinistra,Effloresensi : Ulcus post op Ca mammae

    Location 4 : Regio oralis

    Effloresensi : Stomatitis, crust

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    7/21

    Laboratory Result

    Ureum : 129 mg/dl

    Creatinin : 1,7 mg/dl

    GDS : 66 mg/dl SGOT : 67 U/l

    SGPT : 172 U/l

    Natrium : 129,50 mmol/l

    Kalium : 4,33 mmol/l

    Chloride : 102,30 mmol/l

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    8/21

    Recommended examination

    Consult diet

    Consult ENT Chest X-ray examination

    Punch biopsy

    Immunofluorescence microscopy

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    9/21

    ResumeA 56 years old woman came to the hospital with

    complain rupture of blisters on the back, chest, arms,abdomen, and lipatan paha. Happen 1 week ago, starts

    with appear blisters on the left armpit and ruptured

    later. Shortly thereafter, the patient developswidespread bullae that are easily ruptured. Pasien

    mengeluh susah menelan. Nyeri pada lesi (+), gatal

    pada lesi (+).

    Post operation of mammae (7 days before). MedicationHistory : Tamofen, Dexamethasone, Piroxicam. Fever

    (+) 1 day before bulla presented. Family medical

    history with the same complain (-).

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    10/21

    DiagnosisStevens-Johnson Syndrome

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    11/21

    Treatment

    1. Dexamethasone inj. 1 amp/ 6 h./ iv

    2. Gentamicin 1 amp/12 h./ iv

    3. Afucid cr.

    4. Compress NaCl 0.3%

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    12/21

    PICTURES (9-02-2012)

    Fig. 1 Fig.2

    Figure 1: Stomatitis and crust on the upper and lower lips

    Figure 2: Ulcus post op Ca mammae at the upper chest ofthe patient.

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    13/21

    Fig.3 Fig.4

    Figure 3 and 4: SJS with bulla, vesicle, excoriation, erosion, and

    epidermolysis on the armpit and arms.

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    14/21

    Fig.5 Fig.6

    Figure 5: Bulla on the whole abdomen of the patient

    Figure 6: Erosion, bulla, and excoration on the thighintertrigo

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    15/21

    STEVENS JOHNSON SYNDROME

    Acute life-threatening mucocutaneousreactions characterized byextensive necrosis

    and detachment of the epidermis.

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    16/21

    Idiopathic - 25%

    Drug allergy 50%

    - Analgesic- Antipyretic

    - Anticonvulsan

    - Traditional drug

    And the other are Infections

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    17/21

    TRIAS:

    Skin abnormality : The initial skin lesions are

    characterized by erythematous, dusky

    red, purpuric macules, irregularly shaped,

    which progressively coalesce.Mucous membrane involvement : The

    oral cavity and the vermilion border of the

    lips are almost invariably affected and feature

    painful hemorrhagic erosions coated

    by grayish white pseudomembranes andcrusts of the lips

    Extra-Cutaneous Symptoms : associated with high fever, pain,

    and weakness

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    18/21

    Pathogenesis

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    19/21

    DiagnosisAnamnesis & history taking

    Physical examination

    Laboratory examinationo Low serum albumin and increase in gammaglobulins;

    electrolyte imbalance; acute-phase proteins increased.

    o

    Leukocytosis (+) means the causes is infectiono Eosinofilia (+) means the causes is allergy

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    20/21

    Treatment

    Remove any potential offending and unnecessary

    medications

    Address nutrition, fluid and electrolyte balance

    Oral corticosteroid

    Local skin care with compression to weeping orcrusted sites, bland emollients and mid-potencytopical corticosteroids

    For secondary infection with systemic antibiotics

  • 7/29/2019 Mini Poster - Stevens Johnson Syndrome

    21/21

    Prognosis If the management is fast and adequate, the prognosis

    is better.

    The mortality rate is 5-12%. The prognosis is notaffected by the type or dose of the responsible drug orthe presence of human immunodeficiency virusinfection but depending on the severity of the disease

    and the prior general condition of the patient.